Not Valid for Submission
C50.5 is a non-specific and non-billable diagnosis code code, consider using a code with a higher level of specificity for a diagnosis of malignant neoplasm of lower-outer quadrant of breast. The code is not specific and is NOT valid for the year 2021 for the submission of HIPAA-covered transactions. Category or Header define the heading of a category of codes that may be further subdivided by the use of 4th, 5th, 6th or 7th characters.
The following anatomical sites found in the Table of Neoplasms apply to this code given the correct histological behavior: Neoplasm, neoplastic breast (connective tissue) (glandular tissue) (soft parts) lower-outer quadrant .
Specific Coding for Malignant neoplasm of lower-outer quadrant of breast
Non-specific codes like C50.5 require more digits to indicate the appropriate level of specificity. Consider using any of the following ICD-10 codes with a higher level of specificity when coding for malignant neoplasm of lower-outer quadrant of breast:
Table of Neoplasms
The code C50.5 is included in the table of neoplasms by anatomical site. For each site there are six possible code numbers according to whether the neoplasm in question is malignant, benign, in situ, of uncertain behavior, or of unspecified nature. The description of the neoplasm will often indicate which of the six columns is appropriate.
Where such descriptors are not present, the remainder of the Index should be consulted where guidance is given to the appropriate column for each morphological (histological) variety listed. However, the guidance in the Index can be overridden if one of the descriptors mentioned above is present.
|»Neoplasm, neoplastic |
»breast (connective tissue) (glandular tissue) (soft parts)
Information for Patients
Breast cancer affects one in eight women during their lives. No one knows why some women get breast cancer, but there are many risk factors. Risks that you cannot change include
- Age - the risk rises as you get older
- Genes - two genes, BRCA1 and BRCA2, greatly increase the risk. Women who have family members with breast or ovarian cancer may wish to be tested for the genes.
- Personal factors - beginning periods before age 12 or going through menopause after age 55
Other risks include obesity, using hormone replacement therapy (also called menopausal hormone therapy), taking birth control pills, drinking alcohol, not having children or having your first child after age 35, and having dense breasts.
Symptoms of breast cancer may include a lump in the breast, a change in size or shape of the breast, and discharge from a nipple. Breast self-exams and mammography can help find breast cancer early, when it is most treatable. One possible treatment is surgery. It could be a lumpectomy or a mastectomy. Other treatments include radiation therapy, chemotherapy, hormone therapy, and targeted therapy. Targeted therapy uses substances that attack cancer cells without harming normal cells.
Men can have breast cancer, too, but it is rare.
NIH: National Cancer Institute
- After chemotherapy - discharge (Medical Encyclopedia)
- BRCA1 and BRCA2 gene testing (Medical Encyclopedia)
- Breast biopsy -- stereotactic (Medical Encyclopedia)
- Breast biopsy -- ultrasound (Medical Encyclopedia)
- Breast cancer (Medical Encyclopedia)
- Breast cancer staging (Medical Encyclopedia)
- Breast lump (Medical Encyclopedia)
- Breast self exam (Medical Encyclopedia)
- Hormone therapy for breast cancer (Medical Encyclopedia)
[Learn More in MedlinePlus]